Review summary
Teaching objective: Evaluation and first six months of care of recurrent stereotyped vomiting episodes in a 40-year-old man: a symptom diary, the Rome IV criteria for cyclic vomiting syndrome and its red flags, a cannabis and substance history (to exclude cannabinoid hyperemesis syndrome), a work-up between episodes to exclude other causes (blood count, metabolic and liver panels, lipase, urinalysis, TSH, morning cortisol, celiac serology, CT enterography, and upper endoscopy), a baseline ECG, and anxiety and mood screens (GAD-7, PHQ-9). Management follows the 1842 ANMS and Cyclic Vomiting Syndrome Association guideline: amitriptyline prophylaxis titrated to about 1 mg/kg with ECG checks of the QTc, an abortive plan of nasal sumatriptan and ondansetron at the prodrome, an individualized emergency department protocol, trigger management, and relaxation training. The diagnosis stays provisional because it is clinical, and none of the historical theories of his illness is treated as confirmed.
Historical timeline
| Date | Event | Claims |
|---|---|---|
| February 12, 1809 | Born in Shrewsbury, Shropshire. | CLM-0001 |
| December 1831 | Palpitations and pain about the heart at Plymouth before the Beagle sailed. | CLM-0003 |
| September 1837 | Palpitations; rest in the country on his doctors' advice. | CLM-0004 |
| June 1840 | First mention of periodical vomiting in a letter. | CLM-0005 |
| February 1849 | Incessant vomiting described in a letter, after a winter of weekly vomiting. | CLM-0006 |
| March 10, 1849 | Began about three months of the water cure at Great Malvern (other accounts give March 12). | CLM-0007 |
| July 1, 1849 | Began his health diary, kept until January 1855. | CLM-0008 |
| April 1861 | A short talk at the Linnean Society brought on 24 hours of vomiting. | CLM-0010 |
| April 19, 1882 | Died in Downe, Kent, aged 73, after anginal attacks and heart failure in his last years. | CLM-0002, CLM-0011 |
Evidence claims
D = documented, R = retrospective, S = synthetic.
| Grade | Claim | Certainty | Sources |
|---|---|---|---|
| D | Charles Darwin was born on February 12, 1809, in Shrewsbury, Shropshire, England. | confirmed | Charles Darwin supports |
| D | Darwin died on April 19, 1882, in Downe, Kent, aged 73. Record the death as a fact without detail. |
confirmed | Charles Darwin supports |
| D | While waiting at Plymouth to sail on the Beagle in late 1831, Darwin was troubled with palpitations and pain about the heart, and consulted no doctor for fear of being judged unfit for the voyage. Past history only; the earliest recorded palpitations. |
confirmed | Darwin's Diary: 1831 supports Health of Charles Darwin supports |
| D | In September 1837 he had palpitations and, on his doctors' advice, went to the country to recover. Past history only. |
confirmed | Health of Charles Darwin supports |
| D | Darwin first mentioned periodical vomiting in a letter to W. D. Fox in June 1840. Past history; the documented start of the episodic vomiting. |
confirmed | Darwin's health supports |
| D | In February 1849 he described incessant vomiting to Richard Owen, and in March 1849 he wrote that he had been bad all winter, with dreadful vomiting every week, that his hands trembled, and that his head was often swimming. The anchor for the synthetic presenting episodes at the index visit. |
confirmed | Darwin's health supports Letter from C. R. Darwin to J. D. Hooker, 28 March 1849 (DCP-LETT-1236) supports |
| D | In March 1849 Darwin took his family to Dr. James Manby Gully's water-cure establishment at Great Malvern for about three months; the treatment included heating by spirit lamp, cold towel rubs, cold foot-baths, a wet compress on the stomach, simple food, and short walks. Fixes the index age near the start of the water cure; the treatment itself is not modeled. |
confirmed | Darwin's health supports Letter from C. R. Darwin to J. D. Hooker, 28 March 1849 (DCP-LETT-1236) supports Health of Charles Darwin supports |
| D | Darwin kept a health diary from July 1, 1849, to January 16, 1855, which records near-daily flatulence and notes the acidity of his vomit. Documents the interepisode symptoms; claim only, after the index date. |
confirmed | Darwin's health supports |
| D | Over his adult life he had gastrointestinal distress, including vomiting, retching, and bowel irregularity, with headaches, fatigue, trembling, faintness, dizziness, and skin problems including eczema. The documented symptom complex the episode draws on. |
confirmed | Darwin's health supports Health of Charles Darwin supports |
| D | In April 1861 he wrote that a short talk at the Linnean Society brought on 24 hours of vomiting. Documents social stress as a trigger; claim only, after the index date. |
confirmed | Darwin's health supports |
| D | A British Medical Journal note on his medical history, published after his death, said that in his last years the heart and great vessels were degenerating, anginal attacks became more frequent, signs of heart failure appeared, and he died in one of these attacks. Documents the final illness; claim only, after the episode. |
confirmed | [Medical history of] The late Charles Darwin. British Medical Journal, 29 April 1882, p. 628 supports |
| R | Cyclic vomiting syndrome, perhaps from a mitochondrial DNA disorder, has been proposed as the cause of his illness. Retrospective interpretation. The synthetic episode's provisional modern diagnosis does not confirm it. |
possible | Health of Charles Darwin supports Hayman JA. Darwin's illness revisited. BMJ 2009;339:b4968 context |
| R | Chagas disease, contracted during the Beagle voyage, has been proposed as the cause of his illness. Retrospective interpretation; not tested or coded in the episode. |
disputed | Adler S. Darwin's illness. Nature 1959;184:1102-4 supports Darwin's health supports Health of Charles Darwin supports |
| R | Systemic lactose intolerance has been proposed as the cause of his illness. Retrospective interpretation; not tested or coded in the episode. |
disputed | Campbell AK, Matthews SB. Darwin's illness revealed. Postgrad Med J 2005;81:248-51 supports Health of Charles Darwin supports |
| R | Panic disorder with agoraphobia has been proposed as the explanation of his illness and secluded life. Retrospective psychiatric interpretation; not coded. The episode screens for anxiety without diagnosing an anxiety disorder. |
possible | Barloon TJ, Noyes R Jr. Charles Darwin and panic disorder. JAMA 1997;277:138-41 supports Health of Charles Darwin supports |
| R | Other proposed explanations include hyperventilation, neurasthenia, hypoglycemia, other allergies, Crohn's disease, Helicobacter pylori infection, systemic lupus, Meniere's disease, and psychological or psychosomatic causes. Retrospective interpretations; none is used in the episode. |
disputed | Darwin's health supports Health of Charles Darwin supports |
Modern synthetic problem list
| Grade | Problem | Clinical status | Verification | Placement | Historical claims |
|---|---|---|---|---|---|
| S | Cyclic vomiting syndrome, moderate to severe, meeting Rome IV criteria after a normal work-up; provisional clinical diagnosis | active | provisional | active | CLM-0006, CLM-0009, CLM-0012 |
| S | Recurrent episodes of nausea and vomiting over more than a year, with prodromal trembling, palpitations, and dizziness, and flatulence and fatigue between episodes; cause under evaluation | resolved | confirmed | active | CLM-0006, CLM-0009 |
| S | Common cold, without a vomiting episode; resolved | resolved | confirmed | active |
Synthetic outcome measures
| Grade | Date | Measure | Result | Coding |
|---|---|---|---|---|
| S | 1849-03-03 | Hemoglobin [Mass/volume] in Blood | 14.6 g/dL Reference 13.2-16.6 g/dL |
http://loinc.org · 718-7 |
| S | 1849-03-03 | Leukocytes [#/volume] in Blood by Automated count | 6.4 10*3/uL Reference 3.4-9.6 10*3/uL |
http://loinc.org · 6690-2 |
| S | 1849-03-03 | Platelets [#/volume] in Blood by Automated count | 251 10*3/uL Reference 135-317 10*3/uL |
http://loinc.org · 777-3 |
| S | 1849-03-03 | Sodium [Moles/volume] in Serum or Plasma | 140 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 1849-03-03 | Potassium [Moles/volume] in Serum or Plasma | 4.1 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 1849-03-03 | Chloride [Moles/volume] in Serum or Plasma | 103 mmol/L Reference 98-107 mmol/L |
http://loinc.org · 2075-0 |
| S | 1849-03-03 | Carbon dioxide, total [Moles/volume] in Serum or Plasma | 25 mmol/L Reference 22-29 mmol/L |
http://loinc.org · 2028-9 |
| S | 1849-03-03 | Creatinine [Mass/volume] in Serum or Plasma | 0.94 mg/dL Reference 0.74-1.35 mg/dL |
http://loinc.org · 2160-0 |
| S | 1849-03-03 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1844)/1.73 sq M | 104 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 1849-03-03 | Glucose [Mass/volume] in Serum or Plasma | 88 mg/dL Reference 70-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 1849-03-03 | Calcium [Mass/volume] in Serum or Plasma | 9.5 mg/dL Reference 8.6-10.3 mg/dL |
http://loinc.org · 17861-6 |
| S | 1849-03-03 | Albumin [Mass/volume] in Serum or Plasma | 4.4 g/dL Reference 3.5-5 g/dL |
http://loinc.org · 1751-7 |
| S | 1849-03-03 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 21 U/L Reference 7-55 U/L |
http://loinc.org · 1742-6 |
| S | 1849-03-03 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 19 U/L Reference 8-48 U/L |
http://loinc.org · 1920-8 |
| S | 1849-03-03 | Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma | 68 U/L Reference 40-129 U/L |
http://loinc.org · 6768-6 |
| S | 1849-03-03 | Bilirubin.total [Mass/volume] in Serum or Plasma | 0.7 mg/dL Reference 0.1-1.2 mg/dL |
http://loinc.org · 1975-2 |
| S | 1849-03-03 | Lipase [Enzymatic activity/volume] in Serum or Plasma | 32 U/L Reference 13-60 U/L |
http://loinc.org · 3040-3 |
| S | 1849-03-03 | Thyrotropin [Units/volume] in Serum or Plasma | 1.6 mIU/L Reference 0.45-4.5 mIU/L |
http://loinc.org · 3016-3 |
| S | 1849-03-03 | Cortisol [Mass/volume] in Serum or Plasma | 14.2 ug/dL Reference 6.2-19.4 ug/dL |
http://loinc.org · 2143-6 |
| S | 1849-03-03 | Tissue transglutaminase IgA Ab [Units/volume] in Serum | 1.2 U/mL Reference <=3.9 U/mL |
http://loinc.org · 31017-7 |
| S | 1849-03-03 | IgA [Mass/volume] in Serum or Plasma | 210 mg/dL Reference 70-400 mg/dL |
http://loinc.org · 2458-8 |
| S | 1849-03-03 | Q-T interval corrected | 412 ms Reference <=450 ms |
http://loinc.org · 8636-3 |
| S | 1849-06-09 | Q-T interval corrected | 436 ms Reference <=450 ms |
http://loinc.org · 8636-3 |
| S | 1849-03-03 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 8 | http://loinc.org · 70274-6 |
| S | 1849-03-03 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 6 | http://loinc.org · 44261-6 |
| S | 1849-06-09 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 6 | http://loinc.org · 70274-6 |
| S | 1849-06-09 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | http://loinc.org · 44261-6 |
| S | 1849-09-08 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 5 | http://loinc.org · 70274-6 |
| S | 1849-09-08 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 3 | http://loinc.org · 44261-6 |
| S | 1849-07-21 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | http://loinc.org · 55758-7 |
| S | 1849-07-21 | Total score [AUDIT-C] | 2 | http://loinc.org · 75626-2 |
| S | 1849-07-21 | Cholesterol [Mass/volume] in Serum or Plasma | 178 mg/dL Reference <=200 mg/dL |
http://loinc.org · 2093-3 |
| S | 1849-07-21 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 58 mg/dL Reference >=40 mg/dL |
http://loinc.org · 2085-9 |
| S | 1849-07-21 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 102 mg/dL Reference <=129 mg/dL |
http://loinc.org · 13457-7 |
| S | 1849-07-21 | Triglyceride [Mass/volume] in Serum or Plasma | 90 mg/dL Reference <=149 mg/dL |
http://loinc.org · 2571-8 |
Synthetic vital signs
| Date | Measure | Result | LOINC | Grade |
|---|---|---|---|---|
| 1849-03-03 | Body height | 183 cm | 8302-2 | S |
| 1849-03-03 | Body weight | 71.6 kg | 29463-7 | S |
| 1849-03-03 | Body mass index (BMI) [Ratio] | 21.4 kg/m2 | 39156-5 | S |
| 1849-03-03 | Systolic blood pressure | 118 mm[Hg] | 8480-6 | S |
| 1849-03-03 | Diastolic blood pressure | 74 mm[Hg] | 8462-4 | S |
| 1849-03-03 | Heart rate | 78 /min | 8867-4 | S |
| 1849-03-03 | Respiratory rate | 14 /min | 9279-1 | S |
| 1849-03-03 | Body temperature | 36.6 Cel | 8310-5 | S |
| 1849-03-03 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
| 1849-04-14 | Body height | 183 cm | 8302-2 | S |
| 1849-04-14 | Body weight | 71.4 kg | 29463-7 | S |
| 1849-04-14 | Body mass index (BMI) [Ratio] | 21.3 kg/m2 | 39156-5 | S |
| 1849-04-14 | Systolic blood pressure | 116 mm[Hg] | 8480-6 | S |
| 1849-04-14 | Diastolic blood pressure | 72 mm[Hg] | 8462-4 | S |
| 1849-04-14 | Heart rate | 76 /min | 8867-4 | S |
| 1849-04-14 | Respiratory rate | 14 /min | 9279-1 | S |
| 1849-04-14 | Body temperature | 36.7 Cel | 8310-5 | S |
| 1849-04-14 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
| 1849-06-09 | Body height | 183 cm | 8302-2 | S |
| 1849-06-09 | Body weight | 72.4 kg | 29463-7 | S |
| 1849-06-09 | Body mass index (BMI) [Ratio] | 21.6 kg/m2 | 39156-5 | S |
| 1849-06-09 | Systolic blood pressure | 118 mm[Hg] | 8480-6 | S |
| 1849-06-09 | Diastolic blood pressure | 74 mm[Hg] | 8462-4 | S |
| 1849-06-09 | Heart rate | 72 /min | 8867-4 | S |
| 1849-06-09 | Respiratory rate | 14 /min | 9279-1 | S |
| 1849-06-09 | Body temperature | 36.6 Cel | 8310-5 | S |
| 1849-06-09 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
| 1849-09-08 | Body height | 183 cm | 8302-2 | S |
| 1849-09-08 | Body weight | 72.9 kg | 29463-7 | S |
| 1849-09-08 | Body mass index (BMI) [Ratio] | 21.8 kg/m2 | 39156-5 | S |
| 1849-09-08 | Systolic blood pressure | 116 mm[Hg] | 8480-6 | S |
| 1849-09-08 | Diastolic blood pressure | 72 mm[Hg] | 8462-4 | S |
| 1849-09-08 | Heart rate | 70 /min | 8867-4 | S |
| 1849-09-08 | Respiratory rate | 14 /min | 9279-1 | S |
| 1849-09-08 | Body temperature | 36.6 Cel | 8310-5 | S |
| 1849-09-08 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
| 1849-05-19 | Body height | 183 cm | 8302-2 | S |
| 1849-05-19 | Body weight | 72.1 kg | 29463-7 | S |
| 1849-05-19 | Body mass index (BMI) [Ratio] | 21.5 kg/m2 | 39156-5 | S |
| 1849-05-19 | Systolic blood pressure | 118 mm[Hg] | 8480-6 | S |
| 1849-05-19 | Diastolic blood pressure | 72 mm[Hg] | 8462-4 | S |
| 1849-05-19 | Heart rate | 84 /min | 8867-4 | S |
| 1849-05-19 | Respiratory rate | 16 /min | 9279-1 | S |
| 1849-05-19 | Body temperature | 37.8 Cel | 8310-5 | S |
| 1849-05-19 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 1849-07-21 | Body height | 183 cm | 8302-2 | S |
| 1849-07-21 | Body weight | 72.6 kg | 29463-7 | S |
| 1849-07-21 | Body mass index (BMI) [Ratio] | 21.7 kg/m2 | 39156-5 | S |
| 1849-07-21 | Systolic blood pressure | 116 mm[Hg] | 8480-6 | S |
| 1849-07-21 | Diastolic blood pressure | 72 mm[Hg] | 8462-4 | S |
| 1849-07-21 | Heart rate | 70 /min | 8867-4 | S |
| 1849-07-21 | Respiratory rate | 14 /min | 9279-1 | S |
| 1849-07-21 | Body temperature | 36.6 Cel | 8310-5 | S |
| 1849-07-21 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
Social, functional, and mental status
Social history
- S Has never used cannabis in any form, including edibles, oils, and vaping, and uses no other recreational drugs; asked directly at the first visit
- S Does not smoke or vape; drinks one or two glasses of wine a week, none during episodes
- S Naturalist and writer who works from home; married, with young children; the household is not named in this record
- S Walks most days on a regular route near home; episodes stop all work for a day or two
- S Episodes cluster around social gatherings, speaking to groups, overnight travel, short sleep, and long gaps without food; lying still in a quiet dark room eases them; no habit of long hot baths or showers during episodes
- S Supports: a settled household, absorbing scientific work, daily walks, and a habit of keeping careful notes that suits a symptom diary
Functional status
- S Episodes stop all work for one to two days, every one to three weeks; between them he works most mornings but tires by afternoon
Mental status
- S Alert, courteous, and precise; keeps careful notes of his symptoms; anxious when describing episodes in company; GAD-7 8 and PHQ-9 6, with no thoughts of death or self-harm
Allergies and medications
Allergies
- S No known allergy
Medications
- S Amitriptyline 25 mg oral tablet, one tablet at bedtime
- S Amitriptyline 50 mg oral tablet, one tablet at bedtime
- S Amitriptyline 75 mg oral tablet, one tablet at bedtime
- S Sumatriptan 20 mg nasal spray, one spray at the first sign of an episode
- S Ondansetron 8 mg orally disintegrating tablet at the first sign of an episode
Procedures and immunizations
Procedures
- S CT enterography (CT of the small bowel with oral and intravenous contrast): normal small and large bowel, no obstruction, malrotation, stricture, or wall thickening; normal liver, gallbladder, pancreas, and kidneys
- S Upper endoscopy (esophagogastroduodenoscopy) with duodenal biopsies: normal esophagus, stomach, and duodenum; no ulcer, obstruction, or retained food; duodenal biopsies normal
Immunizations
- S 1848-10-14: Influenza vaccine, 1848-1849 season
- S 1842-06-11: Tetanus, diphtheria, and acellular pertussis (Tdap) booster
- S 1849-07-21: Hepatitis B vaccine (adjuvanted, two-dose series), dose 1
Past medical history
True biography with historical dates; not part of the synthetic care timeline.
- D December 1831: Palpitations and pain about the heart while waiting to sail on the Beagle; no doctor consulted (CLM-0003)
- D September 1837: Palpitations, treated with rest in the country on his doctors' advice (CLM-0004)
- D June 1840: Periodical vomiting, first mentioned in a letter; cause not recorded in the cited source (CLM-0005)
- D February 1849: A winter of dreadful vomiting every week, with trembling hands and a swimming head, and incessant vomiting described in a letter; cause not recorded in the cited source (CLM-0006)
Family history
No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.
Care-plan goals
| Goal | Target date | Status | Outcome |
|---|---|---|---|
| Complete the work-up between episodes (blood and urine tests, ECG, CT enterography, and upper endoscopy) before the six-week visit | 1849-04-14 | completed | All tests normal; Rome IV criteria met; provisional diagnosis of cyclic vomiting syndrome at the consultation |
| At least half as many episodes after three months at the target dose of prophylaxis | 1849-09-08 | completed | About two episodes a month before treatment; one brief episode, aborted at the prodrome, in the three months before the six-month review |
| Carry the abortive medicines and the emergency department letter, and use them at the prodrome | 1849-06-09 | completed | The one episode since starting treatment was treated at the prodrome and settled in about ten hours without an emergency visit; letter carried |
| QTc below 450 ms at the target amitriptyline dose | 1849-06-09 | completed | QTc 436 ms on 75 mg |
| Practice relaxation breathing most days and lower the GAD-7 score by the six-month review | 1849-09-08 | completed | Daily breathing practice; GAD-7 from 8 to 5 |
Interventions
| Intervention | Status | Guideline |
|---|---|---|
| Work-up between episodes: blood count, metabolic and liver panels, lipase, urinalysis, TSH, morning cortisol, celiac serology, a baseline ECG, CT enterography, and upper endoscopy | completed | GL-ANMS-CVS-2019 |
| Gastroenterology consultation to confirm the diagnosis and advise on prophylaxis, abortive treatment, and an emergency plan | completed | GL-ANMS-CVS-2019 |
| Symptom diary: date, prodrome, length and severity of each episode, triggers, medicines taken, and emergency visits | completed | GL-ANMS-CVS-2019 |
| Amitriptyline prophylaxis at bedtime: 25 mg, raised by 25 mg every two weeks to 75 mg (about 1 mg/kg), with an ECG at baseline, at about 50 mg, and at the target dose; judge the response after three months at target and continue for at least a year if it helps | completed | GL-ANMS-CVS-2019 |
| Abortive plan at the first sign of the prodrome: sumatriptan 20 mg nasal spray with ondansetron 8 mg dissolving tablet, a dark quiet room, and small sips of fluid; an individualized emergency department letter for episodes that do not settle | completed | GL-ANMS-CVS-2019 |
| Trigger management: regular meals and sleep, planning around travel and social events, early treatment of infections, and continued avoidance of cannabis | completed | GL-ANMS-CVS-2019 |
| Anxiety and mood: GAD-7 and PHQ-9 at the first visit and every three months; relaxation breathing, with cognitive behavioral therapy offered if symptoms persist | completed | GL-ANMS-CVS-2019, GL-USPSTF-ANX-2023 |
Planned encounters
- 1849-03-03 — Evaluation of recurrent vomiting episodes: history, symptom diary, Rome IV criteria, red flags, cannabis and substance history, anxiety and mood screens, laboratory tests, ECG, and orders for small-bowel imaging and upper endoscopy (ENC-001)
- 1849-04-14 — Six-week follow-up: results, gastroenterology consultation, provisional diagnosis, prophylaxis, and abortive plan (ENC-002)
- 1849-05-19 — Same-day sick visit for a head cold (ENC-005, unscheduled)
- 1849-06-09 — Three-month review: amitriptyline at target dose, ECG, episode diary, and anxiety screen (ENC-003)
- 1849-07-21 — Preventive health visit (ENC-006)
- 1849-09-08 — Six-month review of response to prophylaxis (ENC-004)
Supporting documents
- History and physical
- Progress note 01
- Progress note 02 — Focused Visit (Follow-up)
- Progress note 03 — Sick Visit
- Progress note 04 — Focused Visit (Follow-up)
- Progress note 05 — Preventive Visit
- Progress note 06 — Focused Visit (Care-plan review)
- Gastroenterology referral
- Gastroenterology consultation
- Patient care plan
- Teaching note
- Provenance CSV
C-CDA note documents
Each link opens a readable copy; the XML beside it is the exchange file.
- History and physical (XML)
- Progress note 01 (XML)
- Progress note 02 — Focused Visit (Follow-up) (XML)
- Progress note 03 — Sick Visit (XML)
- Progress note 04 — Focused Visit (Follow-up) (XML)
- Progress note 05 — Preventive Visit (XML)
- Progress note 06 — Focused Visit (Care-plan review) (XML)
- Gastroenterology referral (XML)
- Gastroenterology consultation (XML)
Sources
| ID | Source | Publisher | Type |
|---|---|---|---|
| SRC-0001 | Charles Darwin | Wikipedia | other |
| SRC-0002 | Darwin's health | Darwin Correspondence Project, Cambridge University Library | scholarly |
| SRC-0003 | Letter from C. R. Darwin to J. D. Hooker, 28 March 1849 (DCP-LETT-1236) | Darwin Correspondence Project, Cambridge University Library | primary |
| SRC-0004 | Health of Charles Darwin | Wikipedia | other |
| SRC-0005 | Darwin's Diary: 1831 | PBS, Evolution | other |
| SRC-0006 | [Medical history of] The late Charles Darwin. British Medical Journal, 29 April 1882, p. 628 | The Complete Work of Charles Darwin Online | primary |
| SRC-0007 | Hayman JA. Darwin's illness revisited. BMJ 2009;339:b4968 | PubMed | scholarly |
| SRC-0008 | Adler S. Darwin's illness. Nature 1959;184:1102-4 | PubMed | scholarly |
| SRC-0009 | Campbell AK, Matthews SB. Darwin's illness revealed. Postgrad Med J 2005;81:248-51 | PubMed | scholarly |
| SRC-0010 | Barloon TJ, Noyes R Jr. Charles Darwin and panic disorder. JAMA 1997;277:138-41 | PubMed | scholarly |
| SRC-0011 | HISTMED Master Roster v3 | The Human Record project | other |
Review status
| Review | Status | Notes |
|---|---|---|
| schema validation | not_started | Run scripts/build.ps1 -Conformance. |
| clinical review | not_started | Awaiting clinician review. |
| provenance review | not_started | The episodic vomiting, palpitations, trembling, flatulence, water cure, and health diary are documented; every proposed cause is graded R and none is coded. No statement or health fact is attributed to a real relative or physician in the modern episode. |
| safe messaging review | not_started | GAD-7 and PHQ-9 scores stay below 10, with item 9 scored 0 on a tricyclic, and no behavioral-health diagnosis is coded, so no safety assessment is required; the panic disorder and psychosomatic theories are claims only, marked sensitive. |
Comments and corrections
Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.
Comments appear on the online version of this page.